Literature DB >> 17334042

[Annexin-1: 2nd messanger of the anti-inflammatory actions of glucocorticoids].

Margarida Castro-Caldas1.   

Abstract

Glucocorticoids have important immunosupressive properties, being used as anti-inflammatory therapeutic agents in a wide range of inflammatory and auto-immune pathologies. One of the best studied mechanisms by which glucocorticoids exert most of their anti-inflammatory actions involves the induction of the synthesis and the secretion of the mediator and effector protein annexin 1 (ANXA1). Here we review the molecular and cellular pathways involved on the glucocorticoid-induced synthesis and secretion of ANXA1 in a variety of cell types. Since its discovery as an anti-phospholipase A2 protein, ANXA1 has come a long way to encompass a wide range of cellular effects, the most relevant ones being those that directly modulate the inflammatory response. The results presented in this review open the way to further pharmacological studies which will allow the identification of the role of ANXA1 in inflamatory pathologies, namely rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17334042

Source DB:  PubMed          Journal:  Acta Reumatol Port        ISSN: 0303-464X            Impact factor:   1.290


  2 in total

1.  Differential proteome analysis of human gliomas stratified for loss of heterozygosity on chromosomal arms 1p and 19q.

Authors:  Michael Grzendowski; Marietta Wolter; Markus J Riemenschneider; Christiane B Knobbe; Uwe Schlegel; Helmut E Meyer; Guido Reifenberger; Kai Stühler
Journal:  Neuro Oncol       Date:  2010-01-07       Impact factor: 12.300

2.  Evaluation of topical corticosteroids in children with phimosis through morphological and immunohistochemical analyses of the foreskin.

Authors:  Luis Gustavo Sabino Borges; Maria Flávia Meirelles; Natália Bernardes; Felipe Lopes de Castro; Fernanda Rodrigues Helmo; Laura Penna Rocha; Vicente de Paula Antunes Teixeira; Rosana Rosa Miranda Correa
Journal:  Afr J Paediatr Surg       Date:  2019 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.